Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

608 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Screening of hepatitis E in patients presenting for acute neurological disorders.
Belbézier A, Deroux A, Sarrot-Reynauld F, Colombe B, Bosseray A, Wintenberger C, Dumanoir P, Lugosi M, Boccon-Gibod I, Leroy V, Maignan M, Collomb-Muret R, Viglino D, Vaillant M, Minotti L, Lagrange E, Epaulard O, Dumestre-Perard C, Lhomme S, Lupo J, Larrat S, Morand P, Schwebel C, Vilotitch A, Bosson JL, Bouillet L. Belbézier A, et al. Among authors: leroy v. J Infect Public Health. 2020 Jul;13(7):1047-1050. doi: 10.1016/j.jiph.2019.12.012. Epub 2020 Mar 26. J Infect Public Health. 2020. PMID: 32224109 Free article.
Assessment of selective real-time PCR for quantitation of lamivudine and adefovir hepatitis B virus-resistant strains and comparison with direct sequencing and line probe assays.
Lupo J, Larrat S, Hilleret MN, Germi R, Boyer V, Nicod S, Barguès G, Leroy V, Seigneurin JM, Zarski JP, Morand P. Lupo J, et al. Among authors: leroy v. J Virol Methods. 2009 Mar;156(1-2):52-8. doi: 10.1016/j.jviromet.2008.10.028. Epub 2008 Dec 12. J Virol Methods. 2009. PMID: 19041345
Ultradeep pyrosequencing of NS3 to predict response to triple therapy with protease inhibitors in previously treated chronic hepatitis C patients.
Larrat S, Kulkarni O, Claude JB, Beugnot R, Blum MG, Fusillier K, Lupo J, Tremeaux P, Plages A, Marlu A, Duborjal H, Signori-Schmuck A, Francois O, Zarski JP, Morand P, Leroy V. Larrat S, et al. Among authors: leroy v. J Clin Microbiol. 2015 Feb;53(2):389-97. doi: 10.1128/JCM.02547-14. Epub 2014 Nov 19. J Clin Microbiol. 2015. PMID: 25411182 Free PMC article.
Baseline and post-treatment hepatitis C NS5A resistance in relapsed patients from a multicentric real-life cohort.
Halfon P, Scholtès C, Izopet J, Larrat S, Trimoulet P, Zoulim F, Alric L, Métivier S, Leroy V, Ouzan D, de Lédinghen V, Mohamed S, Pénaranda G, Khiri H, Thélu MA, Plauzolles A, Chiche L, Bourlière M, Abravanel F. Halfon P, et al. Among authors: leroy v. Antivir Ther. 2018;23(4):307-314. doi: 10.3851/IMP3184. Antivir Ther. 2018. PMID: 28730994
608 results